Clinical Trial

Positive Predictive Value (PPV) of Pseudomonas Aeruginosa

Study Description

Positive Predictive Value (PPV) of Pseudomonas Aeruginosa

This is a non-randomized, single-blind post market clinical follow-up study for which 65 patients will be imaged at Rouge Valley Centenary Hospital (Scarborough and Rouge Hospital) who present with a chronic wound and are receiving standard wound care treatment. The MolecuLight i:X imaging device will be used by the study clinician as an adjunctive tool in the assessment of the wound and will be used to guide the targeted sampling of a wound (with curettage scraping), as per current standard of care in the principal investigator's wound care clinic. The acquired tissue sample will then be analysed using conventional gold standard semi-quantitative culture methods to determine bacterial species present, also as per current standard of care in this clinic.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Methods have not been listed for this study. If you require more information about the methods of this study, please inquire with the researcher.

Additional Information

Official Study Title

A Prospective, Single-blind Evaluation of the Positive Predictive Value (PPV) of the MolecuLight i:Xâ„¢ Imaging Device to Predict the Presence of Pseudomonas Aeruginosa in Chronic Wounds

Clinical Trial ID

NCT03290690

ParticipAid ID

9aAZBb